Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy in asthma--fixed or variable dosing in different patients?

Jan Lötvall1

  • 1Department of Respiratory Medicine & Allergology, Göteborg University, Göteborg, Sweden. jan.lotvall@mednet.gu.se

Current Medical Research and Opinion
|November 13, 2004
PubMed
Summary

Combination inhalers simplify asthma therapy by combining inhaled corticosteroids (ICS) and long-acting beta2-agonists. Adjustable dosing may improve asthma control and reduce steroid use compared to fixed dosing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum and Nasal Lavage Fluid Eosinophil-Derived Neurotoxin Levels in Clinically Defined Asthma Phenotypes.

Clinical and translational allergy·2026
Same author

Frozen melanoma tissues yield extracellular vesicles with preserved diagnostic and immunogenic properties.

BMC medicine·2026
Same author

Quantitative proteomic and functional comparison of extracellular vesicles from multiple adipose tissue mesenchymal stem cell donors.

Extracellular vesicles and circulating nucleic acids·2026
Same author

Development of Anti-Inflammatory Extracellular Vesicles by Surface Expression of Syndecan-4.

Journal of extracellular vesicles·2026
Same author

Reduced Mortality in COVID-19 Patients Treated With Inhaled Extracellular Vesicles Expressing CD24.

Journal of extracellular vesicles·2026
Same author

Extracellular vesicle analysis.

Nature reviews. Methods primers·2026

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Combination inhalers simplify asthma management by co-administering inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABAs).
  • Current combination inhalers (Symbicort, Seretide) align with guidelines for patients inadequately controlled on ICS alone.
  • These inhalers may improve adherence and asthma control by preventing sole reliance on LABAs.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of fixed versus adjustable dosing strategies for asthma combination therapy.
  • To explore the potential benefits of symptom-guided adjustable dosing in asthma management.
  • To determine if budesonide/formoterol could serve as both maintenance and reliever therapy.

Main Methods:

  • Review of existing studies comparing fixed-dose and adjustable symptom-guided dosing regimens for asthma.

Related Experiment Videos

  • In vitro experiments investigating potential beneficial interactions between ICS and LABAs in single inhalers.
  • Analysis of clinical data on the efficacy and tolerability of budesonide/formoterol and salmeterol/fluticasone.

    • Main Results:

    • Both fixed and adjustable dosing strategies provide effective asthma control.
    • Adjustable, symptom-guided dosing may enhance asthma control while potentially lowering overall steroid dosage.
    • Formoterol's rapid onset and dose-related effects suggest budesonide/formoterol could be used for both maintenance and relief.

    Conclusions:

    • Both fixed and adjustable dosing strategies are valuable for long-term asthma management.
    • Adjustable dosing offers a promising approach for personalized asthma care, potentially reducing steroid exposure.
    • Individual patient needs and preferences will likely dictate the choice between fixed and adjustable treatment approaches.